anayamalik, Author at European Medical Journal - Page 25 of 120

cancer pain management concept with cannabis laws and opioid use

Cannabis Laws Linked to Less Opioid Prescribing in Cancer

Cannabis laws were associated with lower opioid dispensing among commercially insured patients with cancer across U.S. states.

Conceptual illustration of metabolic syndrome in Down syndrome and dementia risk

Obesity Increases Dementia Risk in Down Syndrome

In adults with Down syndrome, metabolic syndrome was uncommon, but obesity associated with Alzheimer’s dementia risk.

Concept illustration of Aeromonas infections affecting biliary and soft tissue systems

Rural US Experience with Invasive Aeromonas Infections

Invasive Aeromonas infections were uncommon yet severe in a four-year rural U.S. review of cases.

Nirsevimab Lowers RSV Hospitalization in US Infants

Nirsevimab administration was linked to lower RSV hospitalization among U.S. infants this season in analysis of real-world data.

Advanced drug delivery systems for gout and hyperuricemia treatment concept

Advanced Drug Delivery Improves Gout Management

Advanced drug delivery systems may improve outcomes in gout and hyperuricemia by enhancing targeting and tolerability.

Abstract conceptual image of melanoma quality of life during and after immunotherapy, highlighting fatigue and skin symptoms.

Melanoma Quality of Life During and After Immunotherapy

Melanoma quality of life differs during and after immunotherapy, with fatigue, skin issues, and sexual dysfunction.

Patient performing six-minute walking test after pancreatic surgery in hospital corridor

Six-Minute Walk Test Validates Pancreatic Surgery Recovery

The six-minute walking test offers an objective, low-cost assessment of postoperative recovery after pancreatic surgery.

gout flares after stroke concept with inflamed joint

Gout Flares After Stroke Rise in First Week

Gout flares affect one in twenty stroke patients within a week, often the paretic limb, unveiling undiagnosed hyperuricemia.

Close-up of azelastine nasal spray used for SARS-CoV-2 prevention

Azelastine Nasal Spray Shows Preventive Benefit

Azelastine nasal spray reduced PCR-confirmed SARS-CoV-2 infections versus placebo in a Phase II randomized trial in adults.

Young women receiving HPV vaccine illustrating herd protection effect

HPV Vaccine Shows Strong Herd Effect, 17 Years On

Seventeen years after its introduction, HPV vaccine effectiveness shows a significant drop in vaccine-type infections among vaccinated and unvaccinated young women.